Cyteir Therapeutics Inc

NASDAQ:CYT   3:55:45 PM EDT
15.69
+1.03 (+7.03%)
Other Pre-Announcement

Cyteir Therapeutics Reports Third Quarter 2021 Financial Results

Published: 11/12/2021 12:47 GMT
Cyteir Therapeutics Inc (CYT) - Cyteir Therapeutics Reports Third Quarter 2021 Financial Results and Provides Business Highlights.
Q3 Loss per Share $0.33.
Cyteir Therapeutics - Ended Quarter With Approximately $200 Million in Cash to Continue to Advance Pipeline and to Fund Operations Through 2023.